{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:48:09Z","timestamp":1792176489772,"version":"4.4.0"},"reference-count":183,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T00:00:00Z","timestamp":1702857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>The escalation in opioid pain relief (OPR) medications, heroin and fentanyl, has led to an increased use during pregnancy and a public health crisis. Methamphetamine use in women of childbearing age has now eclipsed the use of cocaine and other stimulants globally. Recent reports have shown increases in methamphetamine are selective to opioid use, particularly in rural regions in the US. This report compares the extent of our knowledge of the perinatal outcomes of OPRs, heroin, fentanyl, two long-acting substances used in the treatment of opioid use disorders (buprenorphine and methadone), and methamphetamine. The methodological limitations of the current research are examined, and two important initiatives that will address these limitations are reviewed. Current knowledge of the perinatal effects of short-acting opioids, OPRs, heroin, and fentanyl, is scarce. Most of what we know about the perinatal effects of opioids comes from research on the long-acting opioid agonist drugs used in the treatment of OUDs, methadone and buprenorphine. Both have better perinatal outcomes for the mother and newborn than heroin, but the uptake of these opioid substitution programs is poor (&amp;lt;50%). Current research on perinatal outcomes of methamphetamine is limited to retrospective epidemiological studies, chart reviews, one study from a treatment center in Hawaii, and the US and NZ cross-cultural infant Development, Environment And Lifestyle IDEAL studies. Characteristics of pregnant individuals in both opioid and MA studies were associated with poor maternal health, higher rates of mental illness, trauma, and poverty. Infant outcomes that differed between opioid and MA exposure included variations in neurobehavior at birth which could complicate the diagnosis and treatment of neonatal opioid withdrawal (NOWs). Given the complexity of OUDs in pregnant individuals and the increasing co-use of these opioids with MA, large studies are needed. These studies need to address the many confounders to perinatal outcomes and employ neurodevelopmental markers at birth that can help predict long-term neurodevelopmental outcomes. Two US initiatives that can provide critical research and treatment answers to this public health crisis are the US Environmental influences on Child Health Outcomes (ECHO) program and the Medication for Opioid Use Disorder During Pregnancy Network (MAT-LINK).<\/jats:p>","DOI":"10.3389\/fped.2023.1305508","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T06:59:35Z","timestamp":1702882775000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Opioid, methamphetamine, and polysubstance use: perinatal outcomes for the mother and infant"],"prefix":"10.3389","volume":"11","author":[{"given":"Trecia A.","family":"Wouldes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry M.","family":"Lester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.siny.2019.01.011","article-title":"Stimulants: how big is the problem and what are the effects of prenatal exposure?","volume":"24","author":"Wouldes","year":"2019","journal-title":"Semin Fetal Neonatal Med"},{"key":"B2","year":"2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/GRF.0000000000000418","article-title":"Stimulant use in pregnancy: an under-recognized epidemic among pregnant women","volume":"62","author":"Smid","year":"2019","journal-title":"Clin Obstet Gynecol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/ajo.12823","article-title":"Prescription opioid use in pregnancy","volume":"58","author":"Blandthorn","year":"2018","journal-title":"Aust N Z J Obstetr Gynaecol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/AOG.0b013e3181a5ec6f","article-title":"Methamphetamine use among pregnant women","volume":"113","author":"Terplan","year":"2009","journal-title":"Obstet Gynecol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e:81\u201394","DOI":"10.1097\/AOG.0000000000002235","article-title":"Opioid use and opioid use disorder in pregnancy. Committee opinion No. 711","volume":"711","year":"2017","journal-title":"Am Coll Obstetr Gynecol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"key":"B8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization\u2014united States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/jp.2015.63","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: united States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1056\/NEJMsa1500439","article-title":"Increasing incidence of the neonatal abstinence syndrome in U. S. Neonatal ICUs","volume":"372","author":"Tolia","year":"2015","journal-title":"N Engl J Med"},{"key":"B11","unstructured":"2022"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","article-title":"Drug and opioid-involved overdose deaths\u2014united States 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1097\/AOG.0000000000000208","article-title":"Increase in prescription opioid use during pregnancy among medicaid-enrolled women","volume":"123","author":"Desai","year":"2014","journal-title":"Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"h2101","DOI":"10.11136\/bmj.h2102","article-title":"Exposure to prescription opioid analgesics in utero and risks of neonatal abstinence syndrome: population based cohort study","volume":"350","author":"Desai","year":"2015","journal-title":"Br Med J"},{"key":"B15","year":"2017"},{"key":"B16","author":"Meth","year":"2018"},{"key":"B17","unstructured":"SavageJ\n            JohnstonK\n            ReedC"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e2021050279","DOI":"10.1542\/peds.2021-050279","article-title":"Opioid use disorder and perinatal outcomes","volume":"148","author":"Piske","year":"2021","journal-title":"Pediatrics"},{"key":"B19","year":"2013"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1056\/NEJMc1505541","article-title":"Shifting patterns of prescription opioid and heroin abuse in the United States","volume":"373","author":"Cicero","year":"2015","journal-title":"N Engl J Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1001\/jama.2022.17045","article-title":"US trends in drug overdose mortality among pregnant and postpartum persons, 2017-2020","volume":"328","author":"Bruzelius","year":"2022","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108750","DOI":"10.1016\/j.drugalcdep.2021.108750","article-title":"The continued rise of methamphetamine use among people who use heroin in the United States","volume":"225","author":"Strickland","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am J Public Health"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.drugalcdep.2012.06.016","article-title":"Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand","volume":"127","author":"Wouldes","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B25","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.ntt.2010.01.007","article-title":"Maternal methadone dose during pregnancy and infant clinical outcome","volume":"32","author":"Wouldes","year":"2010","journal-title":"Neurotoxicol Teratol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"E0240905","DOI":"10.1371\/journal.pone.0240905","article-title":"Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months","volume":"15","author":"Wouldes","year":"2020","journal-title":"PLOS ONE"},{"key":"B27","doi-asserted-by":"publisher","first-page":"139.e1","DOI":"10.1016\/j.ajog.2010.10.004","article-title":"Methadone and perinatal outcomes: a retrospective cohort study","volume":"204","author":"Cleary","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1111\/j.1360-0443.2012.03844.x","article-title":"Methadone and perinatal outcomes: a prospective cohort study","volume":"107","author":"Cleary","year":"2012","journal-title":"Addiction"},{"key":"B29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ntt.2013.04.006","article-title":"Psychosocial characteristics and poly-drug use of pregnant women enrolled in methadone maintenance treatment","volume":"38","author":"Davie-Gray","year":"2013","journal-title":"Neurotoxicol Teratol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/00952990601175029","article-title":"Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL)","volume":"33","author":"Derauf","year":"2007","journal-title":"Am J Drug Alcohol Abuse"},{"key":"B31","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/jwh.2022.0118","article-title":"Characteristics of individuals in the United States who used opioids during pregnancy","volume":"32","author":"Nguyen","year":"2023","journal-title":"J Women\u2019s Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M17-0865","article-title":"Prescription opioid use, misuse, and use disorders in US adults: 2015 national survey on drug use and health","volume":"167","author":"Han","year":"2017","journal-title":"Ann Intern Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1521-0391.2010.00064.x","article-title":"Co-occurring psychiatric symptoms are associated with increased psychological, social and medical impairment in opioid dependent pregnant women","volume":"19","author":"Benningfield","year":"2010","journal-title":"Am J Addict"},{"key":"B34","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/01.AOG.0000129403.54061.0e","article-title":"Low back pain during pregnancy: prevalence, risk factors, and outomes","volume":"104","author":"Wang","year":"2004","journal-title":"Obstet Gynecol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1542\/peds.2014-3299","article-title":"Prescription opioid epidemic and infant outcomes","volume":"135","author":"Patrick","year":"2015","journal-title":"Pediatrics"},{"key":"B36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0035-1556740","article-title":"Prescription opioids in pregnancy and birth outcomes: a review of the literature","volume":"4","author":"Yazdy","year":"2015","journal-title":"J Pediatr Genet"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","article-title":"Effects of codeine on pregnancy outcome: results from a large population-based cohort study","volume":"67","author":"Nezvalov\u00e1-Henriksen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"B38","first-page":"e441","article-title":"Narcotic-exposed neonates in a first nations population in northwestern Ontario: incidence and implications","volume":"57","author":"Kelly","year":"2011","journal-title":"Can Fam Physician"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3390\/ph6101221","article-title":"The use of central nervous system active drugs during pregnancy","volume":"6","author":"K\u00e4ll\u00e9n","year":"2013","journal-title":"Pharmaceuticals"},{"key":"B40","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10995-014-1536-6","article-title":"Clinical correlates of prescription opioid analgesic use in pregnancy","volume":"19","author":"Smith","year":"2015","journal-title":"Matern Child Health J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e20164131","DOI":"10.1542\/peds.2016-4131","article-title":"Maternal use of opioids during pregnancy and congenital malformations: a systematic review","volume":"139","author":"Lind","year":"2017","journal-title":"Pediatrics"},{"key":"B42","year":"2022"},{"key":"B43","year":"2018"},{"key":"B44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1093\/bja\/82.6.929","article-title":"Placental transfer of fentanyl in early human pregnancy and its detection in fetal brain","volume":"82","author":"Cooper","year":"1999","journal-title":"Br J Anaesth"},{"key":"B45","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1523\/JNEUROSCI.2470-20.2020","article-title":"Perinatal fentanyl exposure leads to long-lasting impairments in somatosensory circuit function and behavior","volume":"41","author":"Alipio","year":"2021","journal-title":"J Neurosci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9378(56)90674-3","article-title":"The effects of maternal narcotic addiction on the newborn","volume":"71","author":"Goodfriend","year":"1956","journal-title":"Am J Obstet Gynecol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1001\/archpedi.1963.02080050327013","article-title":"Narcotic and methamphetamine use during pregnancy","volume":"106","author":"Sussman","year":"1963","journal-title":"Am J Dis Child"},{"key":"B48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/adc.63.1.81","article-title":"Maternal narcotic abuse and the newborn","volume":"63","author":"Alroomi","year":"1987","journal-title":"Arch Dis Child"},{"key":"B49","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/0002-9378(69)90117-3","article-title":"Pregnancy in narcotics addicts treated by medical withdrawal","volume":"105","author":"Blinick","year":"1969","journal-title":"Am J Obstet Gynecol"},{"key":"B50","first-page":"159","article-title":"Maternal and fetal effects of heroin addiction during pregnancy","volume":"35","author":"Little","year":"1990","journal-title":"J Reprod Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00006254-197407000-00001","article-title":"Heroin addiction and pregnancy","volume":"29","author":"Perlmutter","year":"1974","journal-title":"Obstet Gynecol Surv"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/0002-9378(73)90953-8","article-title":"Narcotic withdrawal in pregnancy: stillbirth incidence with a case report","volume":"116","author":"Rementeria","year":"1973","journal-title":"Am J Obstet Gynecol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/0002-9378(71)90757-5","article-title":"Narcotic addiction in pregnancy","volume":"109","author":"Stone","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0022-3476(73)80550-5","article-title":"Fetal complications of maternal heroin addiction: abnormal growth, infections, and episodes of stress","volume":"83","author":"Naeye","year":"1973","journal-title":"J Pediatr"},{"key":"B55","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1136\/adc.63.1.81","article-title":"Maternal narcotic abuse and the newborn","volume":"63","author":"Alroomi","year":"1988","journal-title":"Arch Dis Child"},{"key":"B56","first-page":"80","article-title":"Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartume adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department","volume":"29","author":"Binder","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"B57","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0889-8545(05)70362-4","article-title":"Opioid dependence during pregnancy","volume":"25","author":"Kaltenbach","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"key":"B58","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/00001703-199812000-00001","article-title":"Methadone in the management of narcotic addiction in pregnancy","volume":"10","author":"Archie","year":"1998","journal-title":"Curr Opin Obstet Gynecol"},{"key":"B59","unstructured":"2005"},{"key":"B60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1542\/peds.58.5.681","article-title":"Differential effects of maternal heroin and methadone use on birthweight","volume":"58","author":"Kandall","year":"1976","journal-title":"Pediatrics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/09595239400185431","article-title":"The effectiveness of methadone maintenance treatment: an overview","volume":"13","author":"Ward","year":"1994","journal-title":"Drug Alcohol Rev"},{"key":"B62","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1360-0443.2012.04039.x","article-title":"Differences in the profile of neonatal abstinence syndrome signs in methadone-versus buprenorphine-exposed neonates","volume":"107","author":"Gaalema","year":"2012","journal-title":"Addiction"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJM197312062892303","article-title":"Neonatal narcotic addiction. Comparative effects of maternal intake of heroin and methadone","volume":"289","author":"Zelson","year":"1973","journal-title":"N Engl J Med"},{"key":"B64","first-page":"21","article-title":"Current concepts in the management of the pregnant opiate addict","volume":"2","author":"Connaughton","year":"1975","journal-title":"Addict Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1749-6632.1978.tb16770.x","article-title":"Management of pregnant drug-dependent women","volume":"311","author":"Finnegan","year":"1978","journal-title":"Ann N Y Acad Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1651-2227.1983.tb09736.x","article-title":"Investigation of 89 children born by drug-dependent mothers. I neonatal course","volume":"72","author":"Olofsson","year":"1983","journal-title":"Acta Paediatrica Scandanavia"},{"key":"B67","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/j.1651-2227.1983.tb09737.x","article-title":"Investigation of 89 children born by drug-dependent mothers. II follow-up 1-10 years after birth","volume":"72","author":"Olofsson","year":"1983","journal-title":"Acta Paediatrica Scandinavia"},{"key":"B68","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ajog.2005.02.075","article-title":"Fetal response to maternal methadone administration","volume":"193","author":"Jansson","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14767050802452291","article-title":"Maternal methadone dosing schedule and fetal neurobehavior","volume":"22","author":"Jansson","year":"2009","journal-title":"J Matern-Fetal Neonatal Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ntt.2003.09.003","article-title":"The effect of methadone treatment on the quantity and quality of human fetal movement","volume":"26","author":"Wouldes","year":"2004","journal-title":"Neurotoxicol Teratol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2012.04.008","article-title":"Neural tract development of infants born to methadone-maintained mothers","volume":"47","author":"Walhovd","year":"2012","journal-title":"Pediatr Neurol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/(SICI)1520-6661(199611\/12)5:6%3C348::AID-MFM11%3E3.0.CO;2-D","article-title":"Neonatal outcome following methadone exposure in utero","volume":"5","author":"Hagopian","year":"1996","journal-title":"J Matern Fetal Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1001\/archpedi.1980.02130230029009","article-title":"Early growth patterns of methadone-addicted infants","volume":"134","author":"Chasnoff","year":"1980","journal-title":"Am J Dis Child"},{"key":"B74","first-page":"357","article-title":"Prenatal drug exposure: effects on neonatal and infant growth and development","volume":"8","author":"Chasnoff","year":"1986","journal-title":"Neurobehav Toxicol Teratol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1001\/jama.1973.03220320013004","article-title":"Methadone maintenance, pregnancy, and progeny","volume":"225","author":"Blinick","year":"1973","journal-title":"J Am Med Assoc"},{"key":"B76","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/0002-9378(77)90652-4","article-title":"Perinatal addiction: outcome and management","volume":"129","author":"Connaughton","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.1479-828X.1987.tb00952.x","article-title":"Maternal narcotic addiction: pregnancy outcome in patients managed by a specialized drug-dependency antenatal clinic","volume":"27","author":"Ellwood","year":"1987","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1479-828X.1989.tb01724.x","article-title":"Outpatient methadone programme for pregnant heroin using women","volume":"29","author":"Giles","year":"1989","journal-title":"Aust N Z J Obstetr Gynaecol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/S0022-3476(76)80027-3","article-title":"A study of factors that influence the severity of neonatal narcotic withdrawal","volume":"88","author":"Ostrea","year":"1976","journal-title":"J Pediatr"},{"key":"B80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/B978-0-12-800634-4.00058-5","article-title":"Neurobehaviour of neonates born to mothers receiving opioid maintenance treatment: methadone and buprenorphine","volume-title":"Neuropathology of drug addictions and substance misuse. Volume 3: General processes and mechanisms, prescription medications, caffeine and areca, polydrug misuse, emerging addictions and non-drug addictions","author":"Wouldes","year":"2016"},{"key":"B81","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1080\/14659891.2022.2106600","article-title":"Opioid substitution in pregnancy a narrative review: contemporary evidence for use of methadone and buprenorphine in pregnancy","volume":"28","author":"Kinsella","year":"2022","journal-title":"J Subst Use"},{"key":"B82","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2165\/11632820-000000000-00000","article-title":"Methadone and buprenorphine for the management of opioid dependence in pregnancy","volume":"72","author":"Jones","year":"2012","journal-title":"Drugs"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.11.013","article-title":"Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome","volume":"79","author":"Jones","year":"2005","journal-title":"Drug Alcohol Dependence"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1056\/NEJMoa2203318","article-title":"Buprenorphine versus methadone for opioid use disorder in pregnancy","volume":"387","author":"Suarez","year":"2022","journal-title":"N Engl J Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2174\/138945012799201612","article-title":"Current research on opioid receptor function","volume":"13","author":"Feng","year":"2012","journal-title":"Curr Drug Targets"},{"key":"B86","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2174\/157015908784533842","article-title":"The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data","volume":"6","author":"Farid","year":"2008","journal-title":"Curr Neuropharmacol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"529.e1","DOI":"10.1016\/j.ajog.2017.01.040","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1203\/PDR.0b013e3181bc035d","article-title":"Prenatal methadone exposure and neonatal neurobehavioral functioning","volume":"66","author":"Velez","year":"2009","journal-title":"Pediatr Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/dev.21532","article-title":"Neonatal abstinence syndrome: neurobehavior at 6 weeks of age in infants with or without phrmacological treatment for withdrawal","volume":"59","author":"Heller","year":"2017","journal-title":"Dev Psychobiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before and after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction"},{"key":"B91","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1360-0443.2006.01321.x","article-title":"Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study","volume":"101","author":"Fischer","year":"2006","journal-title":"Addiction"},{"key":"B93","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenorphine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1111\/add.13462","article-title":"Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child","volume":"111","author":"Zedler","year":"2016","journal-title":"Addiction"},{"key":"B95","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2012.07.001","article-title":"Neonatal outcomes following in utero exposure to methadone or buprenorphine: a national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009","volume":"127","author":"Welle-Strand","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e540","DOI":"10.1542\/peds.2011-3212","article-title":"The committee on drugs and the committee on Fetus and newborn. Neonatal drug withdrawal","volume":"129","author":"Hudak","year":"2012","journal-title":"Pediatrics"},{"key":"B97","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/aje\/kwu190","article-title":"Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis","volume":"180","author":"Brogly","year":"2014","journal-title":"Am J Epidemiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1360-0443.2012.04035.x","article-title":"Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review","volume":"107","author":"Jones","year":"2012","journal-title":"Addiction"},{"key":"B99","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s40263-013-0072-z","article-title":"Buprenorphine use in pregnant opioid users: a critical review","volume":"27","author":"Soyka","year":"2013","journal-title":"CNS Drugs"},{"key":"B100","doi-asserted-by":"publisher","first-page":"CD006318","DOI":"10.1002\/14651858.CDC006318.pub3","article-title":"Maintenance agonist treatments for opiate-dependent pregnant women","volume":"23","author":"Minozzi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/j.1360-0443.2010.03120.x","article-title":"Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis","volume":"105","author":"Cleary","year":"2010","journal-title":"Addiction"},{"key":"B102","author":"Wouldes","year":"2001"},{"key":"B103","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000210042","article-title":"Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study","volume":"15","author":"Bakstad","year":"2009","journal-title":"Eur Addict Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/hup.1224","article-title":"Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women","volume":"26","author":"Metz","year":"2011","journal-title":"Hum Psychopharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series","volume":"96","author":"Kakko","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"B107","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0002-9378(16)33250-1","article-title":"Observation and treatment of neonatal narcotic withdrawal","volume":"127","author":"Madden","year":"1977","journal-title":"Am J Obstet Gynecol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/0002-9378(74)90335-4","article-title":"Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics","volume":"120","author":"Strauss","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0022-3476(05)82214-0","article-title":"Neonatal opiate abstinence syndrome in term and preterm infants","volume":"118","author":"Doberczak","year":"1991","journal-title":"J Pediatr"},{"key":"B110","first-page":"936","article-title":"Relationships between maternal methdone dosage, maternal-neonatal methadone levels, and neonatal withdrawal","volume":"81","author":"Doberczak","year":"1993","journal-title":"Obstet Gynecol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/s0029-7844(02)02387-6","article-title":"Relationship between maternal methadone dosage and neonatal withdrawal","volume":"100","author":"Dashe","year":"2002","journal-title":"Obstet Gynecol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1479-828X.2010.01168.x","article-title":"Perinatal risk factors for the neonatal abstinence syndrome in infants born to women on methadone maintenance therapy","volume":"50","author":"Liu","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0002-9378(98)70379-5","article-title":"Methadone maintenance in pregnancy: a reappraisal","volume":"179","author":"Brown","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1440-1754.1991.tb00360.x","article-title":"Methadone levels and neonatal withdrawal","volume":"27","author":"Mack","year":"1991","journal-title":"J Paediatr Child Health"},{"key":"B115","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1067\/S0002-9378(03)00520-9","article-title":"Maternal methadone dose and neonatal withdrawal","volume":"189","author":"Berghella","year":"2003","journal-title":"Am J Obstetr Gynecol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"F390","DOI":"10.1136\/adc.2003.036863","article-title":"Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome?","volume":"89","author":"Kuschel","year":"2004","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"B117","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jpeds.2010.03.033","article-title":"Relationship between maternal methadone dose at delivery and neonatal abstinence","volume":"157","author":"Seligman","year":"2010","journal-title":"J Pediatr"},{"key":"B118","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1515\/JPM.2007.063","article-title":"Sequela of preterm versus term infants born to mothers on a methadone maintenance program: differential course of neonatal abstinence syndrome","volume":"35","author":"Dysart","year":"2007","journal-title":"J Perinat Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ADM.0b013e3182266a3a","article-title":"The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome","volume":"5","author":"Wachman","year":"2011","journal-title":"J Addict Med"},{"key":"B120","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.pcl.2004.01.011","article-title":"Discharge criteria for the term newborn","volume":"51","author":"Friedman","year":"2004","journal-title":"Pediatr Clin North Am"},{"key":"B121","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1542\/peds.54.5.583","article-title":"Clinical uses of the brazelton neonatal scale","volume":"54","author":"Soule","year":"1974","journal-title":"Pediatrics"},{"key":"B122","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1360-0443.2012.04040.x","article-title":"Neonatal neurobehavior effects following buprenorphine versus methadone exposure","volume":"107","author":"Coyle","year":"2012","journal-title":"Addiction"},{"key":"B123","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1542\/peds.113.S2.631","article-title":"The neonatal intensive care unit network neurobehavioral scale (NNNS)","volume":"113","author":"Lester","year":"2004","journal-title":"Pediatrics"},{"key":"B124","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1542\/peds.113.S2.676","article-title":"Normative neurobehavioral performance of healthy infants on the neonatal instensive care unit network neurobehavioral scale","volume":"113","author":"Tronick","year":"2004","journal-title":"Pediatrics"},{"key":"B125","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N Eng J Med"},{"key":"B126","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00228-011-1049-9","article-title":"Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study","volume":"67","author":"Lacroix","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1552-6909.2011.01330.x","article-title":"Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome","volume":"41","author":"Pritham","year":"2012","journal-title":"J Obstetr Gynecol Neonatal Nurs"},{"key":"B129","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/02791072.1991.10472236","article-title":"Treatment issues for opioid-dependent women during the perinatal period","volume":"23","author":"Finnegan","year":"1991","journal-title":"J Psychoactive Drugs"},{"key":"B130","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1111\/add.13551","article-title":"The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?","volume":"111","author":"Brogly","year":"2016","journal-title":"Addiction"},{"key":"B131","unstructured":"2023"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2021.108844","article-title":"The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs","volume":"225","author":"Mackay","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B133","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1300\/J069v21n01_03","article-title":"Patterns of methamphetamine abuse and their consequences","volume":"21","author":"Cho","year":"2002","journal-title":"J Addict Dis"},{"key":"B134","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"Ciccarone","year":"2011","journal-title":"Prim Care"},{"key":"B135","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1208\/aapsj0901001","article-title":"Dual dopamine\/serotonin releasers as potential medications for stimulante and alcohol addictions","volume":"9","author":"Rothman","year":"2007","journal-title":"AAPS J"},{"key":"B136","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.drugalcdep.2014.10.003","article-title":"Sex differences in drug use among polysubstance users","volume":"145","author":"Lewis","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B137","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/add.a5509","article-title":"Prenatal methamphetamine\u2014impact on the mother and child\u2014a review","volume":"117","author":"Perez","year":"2021","journal-title":"Addiction"},{"key":"B138","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2105\/AJPH.2018.304771","article-title":"Amphetamine- and opioid-affected births: incidence, outcomes, and costs, United States, 2004-2015","volume":"109","author":"Admon","year":"2019","journal-title":"Am J Public Health"},{"key":"B139","doi-asserted-by":"publisher","first-page":"100619","DOI":"10.1016\/j.jacadv.2023.100619","article-title":"Substance use in pregnancy and its associaton with cardiovascular events","volume":"2","author":"Evans","year":"2023","journal-title":"JACC: Advances"},{"key":"B140","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1007\/s10995-012-1033-8","article-title":"Predictors of inadequate prenatal care in methamphetamine-using mothers in New Zealand and the United States","volume":"17","author":"Wu","year":"2013","journal-title":"Matern Child Health J"},{"key":"B141","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11469-019-00207","article-title":"A prospective study of service use in the year after birth by women at high risk for antenatal substance use and mental health disorders","volume":"19","author":"Stevens","year":"2019","journal-title":"Int J Ment Health Addict"},{"key":"B142","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1055\/s-0032-1304818","article-title":"Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes","volume":"29","author":"Shah","year":"2012","journal-title":"Am J Perinatol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0889-8545(05)70361-2","article-title":"Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy","volume":"25","author":"Plessinger","year":"1998","journal-title":"Obstetr Gynecol Clin N A"},{"key":"B144","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0022-3476(87)80125-7","article-title":"Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates","volume":"111","author":"Oro","year":"1987","journal-title":"J Pediatr"},{"key":"B145","first-page":"541","article-title":"Methamphetamine use during pregnancy: outcome and fetal effects","volume":"72","author":"Little","year":"1988","journal-title":"Obstet Gynecol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1651-2227.1994.tb13380.x","article-title":"Amphetamine addiction during pregnancy: 10-year follow-up","volume":"404","author":"Eriksson","year":"1994","journal-title":"Acta Paediatrica Scandanivica"},{"key":"B147","doi-asserted-by":"publisher","first-page":"204","DOI":"10.111\/j.1651-2227.1980.tb07342.x","article-title":"Amphetamine addiction and pregnancy. III. One year follow-up of the children. Psychosocial and pediatric aspects","volume":"85","author":"Billing","year":"1980","journal-title":"Acta Paediatr"},{"key":"B148","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/ADM.0000000000000101","article-title":"Methamphetamines and pregnancy outcomes","volume":"9","author":"Wright","year":"2015","journal-title":"J Addict Med"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1542\/peds.2005-2564","article-title":"The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth","volume":"118","author":"Smith","year":"2006","journal-title":"Pediatrics"},{"key":"B150","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jpeds.2010.04.024","article-title":"Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study","volume":"157","author":"Nguyen","year":"2010","journal-title":"J Pediatr"},{"key":"B151","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s11121-013-0431-5","article-title":"Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment","volume":"15","author":"Abar","year":"2014","journal-title":"Prev Sci"},{"key":"B152","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ntt.2015.07.006","article-title":"Developmental and behavioral consequences of prenatal methamphetamine exposure: a review of the infant development, environment and lifestyle (IDEAL) study","volume":"51","author":"Smith","year":"2015","journal-title":"Neurotoxicol Teratol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ntt.2010.06.009","article-title":"Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand","volume":"33","author":"LaGasse","year":"2011","journal-title":"Neurotoxicol Teratol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1037\/a0031808","article-title":"Cumulative risk and child development","volume":"139","author":"Evans","year":"2013","journal-title":"Psychol Bull"},{"key":"B155","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.drugalcdep.2011.10.003","article-title":"Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomes","volume":"122","author":"Jansson","year":"2012","journal-title":"Drug Alcohol Depend"},{"key":"B156","doi-asserted-by":"publisher","first-page":"39","DOI":"10.33470\/2379-9536.1212","article-title":"Symptomology associated with in utero exposures to polysubstance in an Appalachian population","volume":"5","author":"Lester","year":"2019","journal-title":"Marshall J Med"},{"key":"B157","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.clp.2009.06.002","article-title":"Fetal effects of psychoactive drugs","volume":"36","author":"Salisbury","year":"2009","journal-title":"Clin Perinatol"},{"key":"B158","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1542\/hpeds.2018-0227","article-title":"Increased severity of neonatal abstinence syndrome associated with concomitant antenatal opioid and benzodiazepine exposure","volume":"9","author":"Sanlorenzo","year":"2019","journal-title":"Hosp Pediatr"},{"key":"B159","doi-asserted-by":"publisher","first-page":"396.e1","DOI":"10.1016\/j.ajog.2008.06.088","article-title":"Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates","volume":"199","author":"Seligman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.peds.2016.11.004","article-title":"An atypical withdrawal syndrome in neonates prenatally exposed to gabapentin and opioids","volume":"181","author":"Loudin","year":"2017","journal-title":"J Perinatol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird","year":"2014","journal-title":"Eur Addict Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1055\/s-0040-1716490","article-title":"Hospital outcomes of infants with neonatal opioid withdrawal syndrome at a tertiary care hospital with high rates of concurrent nonopioid (polysubstance) exposure","volume":"39","author":"Morris","year":"2022","journal-title":"Am J Perinatol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/AOG.0000000000003907","article-title":"Polysubstance use among pregnant women with opioid use disorder in the United States, 2007\u20132016","volume":"136","author":"Jarlenski","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1111\/acer.14309","article-title":"Multiple tools are needed for the detection of prenatal alcohol exposure: findings from a community antenatal setting","volume":"44","author":"Stevens","year":"2020","journal-title":"Alcohol Clin Exp Res"},{"key":"B165","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.wombi.2018.11.009","article-title":"Barriers to screening pregnant women for alcohol or other drugs: a narrative synthesis","volume":"32","author":"Oni","year":"2019","journal-title":"Women Birth"},{"key":"B166","doi-asserted-by":"publisher","first-page":"102595","DOI":"10.1016\/j.midw.2019.102595","article-title":"Barriers and facilitators in antenatal settings to screening and referral of pregnant women who use alcohol or other drugs: a qualitative study of midwives\u2019 experience","volume":"81","author":"Oni","year":"2020","journal-title":"Midwifery"},{"key":"B167","unstructured":"WouldesTA\n          2009"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104189","article-title":"Psychosocial stress and methamphetamine use: a mixed-methods study of intersectional stigma and aboriginal and torres strait islander methamphetamine use","volume":"121","author":"Sivak","year":"2023","journal-title":"Int J Drug Policy"},{"key":"B169","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.childyouth.2007.05.013","article-title":"Co-occurring problems for substance abusing mothers in child welfare: matching services to improve family reunification","volume":"29","author":"Choi","year":"2007","journal-title":"Child Youth Service Review"},{"key":"B170","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1111\/bcp.14538","article-title":"Infant drug exposure via breast milk","volume":"88","author":"Verstegen","year":"2022","journal-title":"Br J Clin Pharmacol"},{"key":"B171","first-page":"22","article-title":"Substance use in the breastfeeding woman","volume":"64","author":"Bartholomew","year":"2019","journal-title":"Contemp Ob Gyn"},{"key":"B172","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"B173","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/jp.2017.40","article-title":"Analysis of the factors that influence the finnegan neonatal abstinence scoring system","volume":"37","author":"Gomez-Pomar","year":"2017","journal-title":"J Perinatol"},{"key":"B174","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/ADM.0b013e31817e6105","article-title":"The opioid dependent mother and newborn dyad: nonpharmacologic care","volume":"2","author":"Velez","year":"2008","journal-title":"J Addict Med"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3360","article-title":"An initiative to improve the quality of care of infants with neonatal abstinence syndrome","volume":"139","author":"Grossman","year":"2017","journal-title":"Pediatrics"},{"key":"B176","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1542\/hpeds.2019-0119","article-title":"Optimal care for NAS: are we moving in the wrong direction?","volume":"9","author":"Jansson","year":"2019","journal-title":"Hosp Pediatr"},{"key":"B177","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1056\/NEJMoa2214470","article-title":"Eat, sleep, console approach or usual care for neonatal opioid withdrawal","volume":"388","author":"Young","year":"2023","journal-title":"N Engl J Med"},{"key":"B178","doi-asserted-by":"publisher","first-page":"e20190128","DOI":"10.1542\/peds.2019-0128","article-title":"Prenatal opioid exposure: neurodevelopmental consequences and future research priorities","volume":"144","author":"Conradt","year":"2019","journal-title":"Pediatrics"},{"key":"B179","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1542\/peds.2009-0204","article-title":"Neonatal neurobehavior predicts medical and behavioral outcome","volume":"125","author":"Liu","year":"2010","journal-title":"Pediatrics"},{"key":"B180","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MOP.0000000000000598","article-title":"Coordination of the environmental influences on child health outcomes program","volume":"30","author":"Smith","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"B181","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/MOP.0000000000000606","article-title":"Measurement framework for the environmental influences on child health outcomes research program","volume":"30","author":"Blackwell","year":"2018","journal-title":"Curr Opin Pediatr"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7203a1","article-title":"Medication for opioid use disorder during pregnancy \u2014 maternal and infant network to understand outcomes associated with use of medication for opioid use disorder during pregnancy (MAT-LINK), 2014\u20132021","volume":"72","author":"Miele","year":"2023","journal-title":"MMWR Surveill Summ"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1089\/jwh.2020.8848","article-title":"The MATernaL and infant NetworK to understand outcomes associated with treatment of opioid use disorder during pregnancy (MAT-LINK): surveillance opportunity","volume":"29","author":"Tran","year":"2020","journal-title":"J Women\u2019s Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1305508\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T15:20:26Z","timestamp":1704468026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1305508\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,18]]},"references-count":183,"alternative-id":["10.3389\/fped.2023.1305508"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1305508","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,18]]},"article-number":"1305508"}}